Pneumococcal conjugate second or third-dose vaccines (PCVc) in Armenia
Armenia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 96.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Armenia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Armenia stood at 96.0%. That is the highest value across all 18 years on record.
That represents a change of up 2.1% on the previous year and up 118.2% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Armenia peaked at 96.0% in 2025 and was at its lowest, 0.0%, in 2008.
That places Armenia 27th out of 194 countries with data for 2025, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Armenia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 44.0% | — |
| 2016 | 94.0% | +113.6% |
| 2017 | 94.0% | +0.0% |
| 2018 | 92.0% | -2.1% |
| 2019 | 92.0% | +0.0% |
| 2020 | 92.0% | +0.0% |
| 2021 | 93.0% | +1.1% |
| 2022 | 93.0% | +0.0% |
| 2023 | 94.0% | +1.1% |
| 2024 | 94.0% | +0.0% |
| 2025 | 96.0% | +2.1% |
Armenia compared with similar countries
- Armenia's 96.0% is above the median for upper middle income countries, which is 76.0%, 1.3× the median. (57 countries reporting)
- Armenia's 96.0% is above the median for Europe & Central Asia, which is 87.0%, 1.1× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 41.6% | 0.0% | 94.0% | 10 |
| 2020s | 93.7% | 92.0% | 96.0% | 6 |
Countries ranked near Armenia
More health data for Armenia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.966 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,466 deaths per 1,000 people (2090)
- Number of infants who die before age 1 33 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.1726 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0282 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5455 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Armenia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Armenia was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Armenia?
- The highest recorded value was 96.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Armenia?
- The lowest recorded value was 0.0% in 2008.
- How does Armenia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Armenia ranks 27th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Armenia?
- Over the last ten years it is up 118.2%. The long-run trend across the full record is volatile.
- Where does this Armenia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).